SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-22-007285
Filing Date
2022-11-09
Accepted
2022-11-09 15:26:19
Documents
48
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q xbit20220930_10q.htm   iXBRL 10-Q 755652
2 EXHIBIT 31.1 ex_442484.htm EX-31.1 10454
3 EXHIBIT 31.2 ex_442485.htm EX-31.2 10446
4 EXHIBIT 32.1 ex_442486.htm EX-32.1 6093
  Complete submission text file 0001171843-22-007285.txt   3300661

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA xbit-20220930.xsd EX-101.SCH 28130
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xbit-20220930_cal.xml EX-101.CAL 27908
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xbit-20220930_def.xml EX-101.DEF 192976
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE xbit-20220930_lab.xml EX-101.LAB 177476
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xbit-20220930_pre.xml EX-101.PRE 212031
42 EXTRACTED XBRL INSTANCE DOCUMENT xbit20220930_10q_htm.xml XML 444413
Mailing Address 5217 WINNEBAGO LANE BUILDING 4, SUITE 100 AUSTIN TX 78744
Business Address 5217 WINNEBAGO LANE BUILDING 4, SUITE 100 AUSTIN TX 78744 512-386-2900
XBiotech Inc. (Filer) CIK: 0001626878 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37347 | Film No.: 221372266
SIC: 2834 Pharmaceutical Preparations